As per DelveInsight, the global Hemostats Market was valued at USD 3.64 billion in 2021 and growing at a CAGR of 5.72% during the forecast period (2022 to 2027), it is anticipated to reach USD 5.07 billion by 2027. Some of the key factors, such as the increasing number of surgical procedures, the growing focus on blood loss management during surgeries, emphasis on improving the safety and usability of Hemostats for end users, and technological advancements, are anticipated to drive the Hemostats Market. The leading companies in the Hemostats Market include Baxter International Inc., Johnson and Johnson, GELITA Medical, B. Braun Melsungen AG, Hemostasis LLC, Stryker Corporation, Pfizer, Mallinckrodt, CryoLife, Integra Life Sciences, Cura Medical, Meril Life Sciences, Beijing Datsing Bio-Tech, Zhonghui Shengxi, Curasan AG, Teflex Inc, Biotemed, BD, Biom’up, Foryou Medical, and others.
DelveInsight’s “Hemostats Market Insight, Competitive Landscape and Market Forecast – 2027” research report provides the current and forecasted Hemostats market size, share, and trends analysis for the next five years. Moreover, it also highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.
Hemostats Market: Overview
Hemostats are medical devices loaded with hemostatic agents, which are used when bleeding cannot be controlled by primary methods such as ligature or the application of pressure. These Hemostats can be in the form of flowable gelatins, thrombins, oxidized regenerated cellulose, etc.
DelveInsight’s “Hemostats Market Report” provides an in-depth assessment of the market, segmented by type (thrombin-based Hemostats, oxidized regenerated cellulose-based Hemostats, gelatin-based Hemostats, collagen-based Hemostats, and others), application (general surgery, neurosurgery, orthopedic surgery, reconstructive surgery, others), formulant (matrix & gel Hemostats, sponge Hemostats, powder Hemostats, and others), end-user (hospitals and clinics, ambulatory surgical centers, and others), geography (North America, Europe, Asia-pacific, and rest of the world).
As per the assessment, in the formulant segment of the Hemostats market, the matrix and gel category is estimated to register significant growth in terms of revenue in the coming years owing to various advantages associated with these product categories. Matrix and gel have better biocompatibility and clotting characteristics when used during surgeries.
The rising number of surgical procedures worldwide is one of the key factors driving the Hemostats Market growth. According to the World Health Organization (2019), 421 million hospitalizations occur due to surgeries annually all around the globe, out of which 42.7 million procedures result in the occurrence of adverse events such as excessive bleeding, sepsis, and cardiovascular consequences, among others. Surgical procedures have various purposes, such as cesarean operations, aesthetic purposes, and injuries, among others. Moreover, technological advancements in developing new and innovative products are also anticipated to drive market growth. Despite several favorable factors, some of the key aspects, such as the dearth of skilled professionals for the efficient use of Hemostats, along with its high cost, may restrict the Hemostats market growth.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight into Hemostats Types and Emerging Products
Hemostats – Global Market Assessment and Forecast
Among all the regions, North America is anticipated to dominate the global Hemostats market in terms of revenue. One of the prominent factors supporting the growth of the North American Hemostats market is the rising number of surgeries in the region. As per reports of the Stanford Healthcare Surgery Statistics (2019), the United States recorded 48 million patient surgery cases in the year 2018, while the cardiovascular system and digestive systems recorded 7.3 million surgeries and 6.1 million surgeries, respectively. The rising number of surgeries is anticipated to drive the demand for Hemostats. Moreover, the advanced healthcare infrastructure, the presence of a large patient population base, a highly potent market in terms of product development and launches, and the local presence of key market players are also anticipated to influence the Hemostats Market growth in a positive direction.
Interested in knowing how the market will grow by 2027? Click to get a snapshot of Hemostats Market Trends and Developments
Over the years, the Hemostats market has evolved significantly owing to the active participation of the global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered. Some of the major advancements in the Hemostats Market in recent years include –
- On January 12, 2023, Medcura, Inc., announced that the US FDA has granted the coveted Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat. LifeGel™ is the first and only hemostatic agent to receive Breakthrough Device Designation seeking a new and highly differentiated indication: in surgical procedures (except in ophthalmic and urological) as an adjunctive hemostatic device when control of minimal, mild, and moderate bleeding by conventional procedures is ineffective or impractical.
- In April 2022, Ethicon (Johnson & Johnson) launched Enseal XI Straight Jaw Tissue Sealer, which is a matrix and gel-based hemostat that has easy access to the target tissue in multiple surgical procedures with greater efficiency.
- In February 2022, Dolphin Hemostats under Futura SurgiCare Pvt. Ltd. launched various hemostatic products under the brand name Hemostax which is an oxidized regenerated cellulose type hemostat.
- In January 2022, the US FDA approved Surgicel Brand Absorbable Hemostat for detecting metal particles in the cut Oxidized Regenerated Cellulose (ORC).
- In July 2021, Medcura Inc. launched Rapid-Seal, which is an antibacterial hemostatic high-performance gel that assists in providing better wound treatment and fights infections with antibacterial capabilities.
- In February 2021, FDA approved the use of the EndoClot Polysaccharide Hemostatic System, manufactured by EndoClot Inc. This hemostatic system is said to control the bleeding rapidly and efficiently in case of gastrointestinal surgeries.
Learn more about the ongoing development in the market @ Hemostats Market – Clinical and Commercial Development Activities
Globally, some of the leading MedTech giants working in the Hemostats Market include Baxter International Inc., Johnson and Johnson, GELITA Medical, B. Braun Melsungen AG, Hemostasis LLC, Stryker Corporation, Pfizer, Mallinckrodt, CryoLife, Integra Life Sciences, Cura Medical, Meril Life Sciences, Beijing Datsing Bio-Tech, Zhonghui Shengxi, Curasan AG, Teflex Inc, Biotemed, BD, Biom’up, Foryou Medical, and others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to very high competitiveness in the domain.
Learn how new players’ entries will transform the market dynamics in the coming years @
Scope of the Hemostats Market Report:
- Study Period – 2019-2027
- Hemostats Market Assessment –
- By Type – Thrombin-based Hemostats, oxidized regenerated cellulose-based Hemostats, gelatin-based Hemostats, collagen-based Hemostats, and Others
- By Application – General surgery, neurosurgery, orthopedic surgery, Reconstructive surgery, others
- By Formulant – Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, and Other
- End-User – Hospitals and Clinics, Ambulatory Surgical Centers, and Others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views
- Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
Table of Content
|3||Regulatory and Patent Analysis|
|4||Hemostats Market Key Factors Analysis|
|5||Hemostats Porter’s Five Forces Analysis|
|6||COVID-19 Impact Analysis on the Hemostats Market|
|7||Hemostats Market Layout|
|8||Hemostats Global Company Share Analysis – Key 3–5 Companies|
|9||Hemostats Product Profiles and Key Companies|
Reach out to us to get a more detailed overview of the market @
Other Trending Report by DelveInsight
Global Absorbable Hemostats Market is expected to grow at a CAGR of 6.47% during the forecast period (2022-2027). Some of the key companies such as B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Stryker, Samyang Holdings Corporation and others, are actively working in the Absorbable Hemostats Market.
“Hemostasis and Tissue Sealing Agents Market Insight, Competitive Landscape, and Market Forecast, 2027’ report delivers an in-depth understanding of historical and forecasted Hemostasis, and Tissue Sealing Agents market size, share, and trends across geographies such as North America, Europe, APAC, and RoW. Moreover, it also covers emerging products and key companies operating in the market.
The global Surgical Equipments Market is anticipated to grow at a CAGR of 7.87% during the forecast period from 2022 to 2027. Several MedTech players such as B Braun Melsungen AG, Boston Scientific Corporation, Cadence, CONMED Corporation, Medtronic PLC, Olympus Corporation, Siemens Healthineers, Smith & Nephew, Stryker Corporation, Johnson & Johnson (Ethicon), Integra LifeSciences Holdings Corporation, and others, are operating in the Surgical Equipments Market.
The global Surgical Drainage Devices Market was valued at USD 1.85 billion in 2021 and is estimated to grow at a CAGR of 5.67% during the forecast period (2022–2027) to reach USD 2.57 billion by 2027. Some of the key market players operating in the Surgical Drainage Devices market include Medtronic, Cardinal Health Inc., Zimmer Biomet, B.Braun Melsungen AG, Cook Medical, Acelity L.P Inc., Medtronic Plc., Poly Medicure, Global Medikit, Degania Silicone, Stryker Corporation, Teleflex Incorporated, Smith & Nephew plc., and others.
The global surgical sealant and adhesives market was valued at USD 2.18 billion in 2021, growing at a CAGR of 7.58% during the forecast period from 2022 to 2027 to reach USD 3.39 billion by 2027. Some of the key companies working in the market include Baxter, BD, Johnson & Johnson, CryoLife, Inc., Integra LifeSciences, Ocular Therapeutix, Inc., Grünenthal, Advamedica Inc., Polyganics, SkinStitch, LLC, Cardinal Health, Cohera Medical, Connexicon medical, and others.
“Surgical Bleeding Market Insight, Competitive Landscape, and Market Forecast, 2027’ report delivers an in-depth understanding of historical and forecasted Surgical Bleeding Market size, share, and trends across geographies such as North America, Europe, APAC, and RoW. Moreover, it also covers emerging products and key companies operating in the market.
“Surgical Bleeding Pipeline Insight, 2023” report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Surgical Bleeding market. It also provides a detailed picture of the Surgical Bleeding pipeline landscape and in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Learn How the MedTech Devices Market is evolving with the ongoing clinical and commercial developments in the domain: MedTech Market Outlook
Manager (Marketing & Branding)